Peptoid−Peptide Hybrids as Potent Novel Melanocortin Receptor Ligands

Department of Medicinal Chemistry, Utrecht Institute for Pharmaceutical Sciences, Utrecht University, P.O. Box 80082, 3508 TB Utrecht, The Netherlands.
Journal of Medicinal Chemistry (Impact Factor: 5.45). 07/2005; 48(13). DOI: 10.1021/jm0490033
Source: OAI


All possible peptoid-peptide hybrids of an MC4 receptor agonist were synthesized and investigated on cells expressing different melanocortin (MC) receptor subtypes and for rat grooming behavior. In general, receptor selectivity remained while affinity and potency were decreased. The length of the functional group of Trp was more important for MC3 and MC5 than for MC4 receptor binding. In general, the potency of the peptoid-peptide hybrids to increase rat excessive grooming behavior correlated well with MC4 receptor pharmacology.

Download full-text


Available from: Roger Adan, May 14, 2014
  • [Show abstract] [Hide abstract]
    ABSTRACT: Conventional constant modulus algorithms (CMAs) suffer shortcomings of slow convergence rate and possibility of improper convergence, which obstruct their application in real-time multiuser detection for CDMA cellular system. This paper focuses on developing new algorithms to alleviate these problems. Three new CMAs, recursive variable step size CMA, normalized constrained CMA and recursive variable step size constrained CMA, are obtained under a uniform framework. Interestingly they can be expressed in a general form. Since they automatically and adaptively choose the optimal variable step size there is no need to worry about whether the step size works and they converge much faster. To solve the modulus parameter sensitivity problem of constrained CMA, modulus parameter correction is integrated into RVSS-CCMA. Various simulations validate the efficiency and robustness of our new algorithms, especially the RVSS-CCMA with modulus parameter correction
    Vehicular Technology Conference, 2001. VTC 2001 Fall. IEEE VTS 54th; 02/2001
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: Replacing the Pro6 in the p6(Gag)-derived 9-mer "P-E-P-T-A-P-P-E-E" with N-substituted glycine (NSG) residues is problematic. However, incorporation of hydrazone amides ("peptoid hydrazones") can be readily achieved in library fashion. Furthermore, reduction of these hydrazones to N-substituted "peptoid hydrazides" affords a facile route to library diversification. This approach is demonstrated by application to Tsg101-binding compounds designed as potential HIV budding antagonists. [reaction: see text]
    Organic Letters 11/2006; 8(22):5165-8. DOI:10.1021/ol0622211 · 6.36 Impact Factor
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: Intensive efforts have been made to develop potent and selective ligands for certain human melanocortin receptors as possible treatments for obesity and sexual dysfunction due to the role of these receptors in feeding behavior, energy homeostasis, sexual function, etc. A number of novel alpha-MSH analogues were designed and synthesized primarily on the basis of our previous MTII NMR structure. In these peptide analogues, a disulfide or lactam bridge between residues at positions 5 and 8 was used as a conformational constraint to enhance the beta-turn spanning His6 and D-Phe7, while the pharmacophore group in Arg8 was mimicked via Nalpha-alkylation of residues 8 or 9 with the guanidinylbutyl group. Biological assays for binding affinities and adenylate cyclase activities for the hMC1R, hMC3R, hMC4R, and hMC5R showed that three analogues have good binding affinity for the hMC4R (0.7-4.1 nM), but have no binding affinity up to 10 microM at the other three melanocortin receptors. Interestingly, the three hMC4R selective analogues display only 50% binding efficiency, suggesting there is allosteric modulation of the melanocortin-4 receptor. These analogues were found to act as antagonists of the hMC4R. This result represents a discovery of very selective peptide-based antagonists for the hMC4R. The high selectivity may be due to the strong conformational constraint via ring contraction as compared to MTII, and the rigid conformation preferred by these new ligands allows them to recognize only the hMC4R, but not to activate the second messenger. The MTII NMR structure-based design thus not only examined the structural model of melanocortin ligands, but also yielded new biologically unique alpha-MSH analogues.
    Journal of Medicinal Chemistry 12/2006; 49(23):6888-96. DOI:10.1021/jm060768f · 5.45 Impact Factor
Show more